The Use of SARS-CoV-2-Positive Donors in Hematopoietic Stem Cell Transplantation

BACKGROUND: Since 2019, the SARS-CoV-2 pandemic has become a global issue due to its high fatality rate. Over time, the characteristics of the virus have evolved and led to the creation of an omicron strain with higher infectivity but a significantly decreased fatality rate. For patients in urgent n...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Meng, Qian, Chongsheng, Zhou, Haixia, Cao, Yaqin, Xu, Mingzhu, Zhang, Tongtong, Xue, Shengli, Sun, Aining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141187/
https://www.ncbi.nlm.nih.gov/pubmed/37236865
http://dx.doi.org/10.1016/j.transproceed.2023.04.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141187/
https://www.ncbi.nlm.nih.gov/pubmed/37236865
http://dx.doi.org/10.1016/j.transproceed.2023.04.027

Ejemplares similares